James Ryan, MD
Adult Reconstructive Orthopaedic Surgery · Plano, TXNPI 1386098150
Payments from drug & device makers
Across 39 payments — averaging $99.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medinc Of Texas$1K
- Omnilife Science, Inc$143
- Bioventus LLC$131
- Encore Medical, LP$114
- Johnson & Johnson$87
- plus $300 from 10 others
What the payments were for
- Travel & lodging$1,18631%
- Food & beverage$1,48738%
- Education$1,20031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $1,899 |
| Medinc Of Texas | 1 | $1,200 |
| Omnilife Science, Inc | 1 | $143 |
| Bioventus LLC | 4 | $131 |
| Encore Medical, LP | 1 | $114 |
| Johnson & Johnson | 4 | $87 |
| Ferring Pharmaceuticals Inc. | 4 | $82 |
| Smith+Nephew | 2 | $52 |
| Davol Inc. | 1 | $31 |
| Advanced Oxygen Therapy Inc. | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $22 |
| Kerecis Limited | 1 | $20 |
| Avanos Medical | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Ossur Americas, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALVATION$861
- MAKO$703
- Apollo Hip V (FKA) OMNIHip$143
- DJO SURGICAL$114
How this compares
$3,874 in reported general payments places this provider in the 20th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.
See all adult reconstructive orthopaedic surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 86 | $974 |
| Meloxicam | 380 | $810 |
| Tramadol Hcl | 68 | $659 |
| Celecoxib | 36 | $533 |
| Cephalexin | 24 | $385 |
| Gabapentin | 64 | $321 |
| Cyclobenzaprine Hcl | 33 | $310 |
| Methylprednisolone | 22 | $138 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $56 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $24 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Plano
- John BarringtonPlano$2.2M
- Roger EmersonPlano$1M
- Richard ReitmanPlano$300K
- Kwame EnninPlano$132K
- Tyler GoldbergAustin$4.6M
- Antonia ChenDallas$4.1M
- Donald HohmanDallas$1M
- Marcus FordFort Worth$401K
- Steven WeedenFort Worth$370K
- David Rodriguez-QuintanaBellaire$366K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.